Turning Cells into Tiny Factories

Phages are viruses that attack bacteria. People have been using phages to treat infections for over a hundred years, but in most cases they just don't work as well as antibiotics. Paul Garofolo is the co-founder and CEO of Locus Biosciences. His problem is this: How do you geneti ...  Show more

David Autor is a labor economist at MIT. He has written about how the arrival of personal computers increased inequality among American workers. But when it comes to AI, David thinks there could be a different outcome. Read David’s article about AI in Noema Magazine. In this epis ...  Show more

For all the exciting developments in the synthetic biology industry, there are also concerns. People can edit genes in their garages these days, so who’s regulating this space?Plus - we’ll hear about the exciting new business models with biology at their core, including one of th ...  Show more

In this week’s series focusing on business and science, we start things off by looking at the world of synthetic biology.The industry is estimated to be worth around $30bn in the next few years, but how is that money actually made?We speak to businesses across the world to find o ...  Show more

This week, we deep-dive into the world of genome engineering and yeast organisms with Leslie Mitchell. She’s the Co-founder and CEO of Neochromosome, a synthetic biology company specialising in whole chromosome delivery and highly automated synthesis of complex DNA. Leslie, one o ...  Show more

Ramya Swaminathan is the CEO of Malta Inc, a company that spun out of Google’s moonshot factory in 2018 to work on an energy storage solution using the existing power grid. One thing holding the world back from a transition to clean energy: electricity generated from sources like ...  Show more